Evidence map›Paper›PMID 37821487›Full record

ArticleScientific reports2023

A novel monoclonal antibody reveals the enrichment of NADPH oxidase 5 in human splenic endothelial cells.

Zsolt Szeles, Gábor L Petheő, Bence Szikora, Imre Kacskovics, Miklós Geiszt

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Zsolt SzelesDepartment of Physiology, Faculty of Medicine, Semmelweis University, PO Box 259, 1444, Budapest, Hungary.
Gábor L PetheőDepartment of Physiology, Faculty of Medicine, Semmelweis University, PO Box 259, 1444, Budapest, Hungary.
Bence SzikoraImmunoGenes Ltd., Budakeszi, Hungary.
Imre KacskovicsImmunoGenes Ltd., Budakeszi, Hungary.
Miklós GeisztDepartment of Physiology, Faculty of Medicine, Semmelweis University, PO Box 259, 1444, Budapest, Hungary. geiszt.miklos@med.semmelweis-univ.hu.
Semmelweis University · HUImmunoGenes (Hungary) · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Members of the NOX/DUOX family of NADPH oxidases are responsible for regulated ROS production in diverse cells and tissues. Detection of NOX/DUOX proteins at the protein level remains an important challenge in the field. Here we report the development and characterization of a novel anti-NOX5 monoclonal antibody, which recognizes the human NOX5 protein in both Western blot, immunocytochemistry, and histochemistry applications. With the help of the antibody we could successfully detect both heterologously and endogenously expressed NOX5 in mammalian cells. Furthermore, we could also detect NOX5 protein in the human spleen, testis, and ovary. Immunohistochemical studies on human testis revealed that NOX5 localized to spermatogenic cells. This expression pattern was also supported by the result of in silico analysis of single-cell RNA sequencing data that indicated that NOX5 protein is present in developing spermatids and spermatocytes. Mature spermatozoa, however, did not contain detectable NOX5. In the human ovary, both immunostaining and single-cell RNA sequencing suggest that NOX5 is expressed in interstitial fibroblasts and theca cells. We also analyzed vascular cells for the presence of NOX5 and we found that NOX5 expression is a fairly specific feature of splenic endothelial cells.

Indexed as

Antibodies, MonoclonalMembrane ProteinsAnimalsEndothelial CellsFemaleHumansMaleMammalsNADPH Oxidase 5NADPH OxidasesReactive Oxygen SpeciesSpleenTestisAntibodies, MonoclonalMembrane ProteinsNADPH Oxidase 5NADPH OxidasesReactive Oxygen Species

Identifiers

PMID37821487
PMCPMC10567692
OpenAlexW4387539682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.